Holen Sie sich die Stockscreener-App
0.3701
4.86%
-0.0189
Vorhandelsmarkt:
.37
-0.000100
-0.03%
Schlusskurs vom Vortag:
$0.389
Offen:
$0.41
24-Stunden-Volumen:
3.50M
Relative Volume:
0.35
Marktkapitalisierung:
$18.63M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.88M
KGV:
-0.1594
EPS:
-2.3215
Netto-Cashflow:
$-10.85M
1W Leistung:
+19.00%
1M Leistung:
+73.59%
6M Leistung:
+59.80%
1J Leistung:
-67.82%
1-Tages-Spanne:
$0.3669
$0.41
1-Wochen-Bereich:
$0.2986
$0.4337
52-Wochen-Spanne:
$0.15
$1.50
Processa Pharmaceuticals Inc Stock (PCSA) Company Profile
Firmenname
Processa Pharmaceuticals Inc
Sektor
Branche
Telefon
443-776-3133
Adresse
601 21ST STREET, SUITE 300, VERO BEACH
Vergleichen Sie PCSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
0.3701 | 21.71M | 0 | -12.88M | -10.85M | -2.3215 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-25 | Eingeleitet | H.C. Wainwright | Buy |
Processa Pharmaceuticals Inc Aktie (PCSA) Neueste Nachrichten
Can Processa Pharmaceuticals Inc. recover in the next quarterDividend Hike & AI Forecast for Swing Trade Picks - newser.com
Will Processa Pharmaceuticals Inc. stock remain a Wall Street favoriteJuly 2025 Opening Moves & Fast Moving Trade Plans - newser.com
Can trapped investors hope for a rebound in Processa Pharmaceuticals Inc.July 2025 Short Interest & Smart Money Movement Alerts - newser.com
Trend analysis for Processa Pharmaceuticals Inc. this weekPortfolio Risk Report & Weekly Consistent Profit Watchlists - newser.com
Is Processa Pharmaceuticals Inc. meeting your algorithmic filter criteriaTrade Performance Summary & Verified High Yield Trade Plans - newser.com
Quantitative breakdown of Processa Pharmaceuticals Inc. recent move2025 Sector Review & Daily Oversold Bounce Ideas - newser.com
Will Processa Pharmaceuticals Inc. stock sustain high P E ratiosJuly 2025 Recap & Growth Focused Stock Reports - newser.com
Will Processa Pharmaceuticals Inc. stock benefit from infrastructure spendingMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Processa Pharmaceuticals Inc. stock prediction for this weekEarnings Recap Summary & AI Enhanced Trading Alerts - newser.com
Is Processa Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 Short Interest & Weekly Breakout Watchlists - newser.com
Is Processa Pharmaceuticals Inc. stock ready for a breakoutRate Hike & Community Verified Trade Signals - newser.com
Analyzing Processa Pharmaceuticals Inc. with risk reward ratio chartsRate Hike & AI Enhanced Trading Alerts - newser.com
Is Processa Pharmaceuticals Inc. forming a bottoming base2025 Stock Rankings & Real-Time Chart Pattern Alerts - newser.com
Can a trend reversal in Processa Pharmaceuticals Inc. lead to recoveryWeekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - newser.com
Pattern recognition hints at Processa Pharmaceuticals Inc. upsidePortfolio Gains Summary & Daily Chart Pattern Signals - newser.com
Will Processa Pharmaceuticals Inc. stock split again soon2025 Top Gainers & Daily Price Action Insights - newser.com
Published on: 2025-11-02 22:33:32 - newser.com
Can you recover from losses in Processa Pharmaceuticals Inc.2025 Institutional Moves & Weekly High Return Stock Forecasts - newser.com
Published on: 2025-11-02 06:25:47 - newser.com
How Processa Pharmaceuticals Inc. stock compares to growth peersEarnings Overview Summary & Community Consensus Picks - newser.com
Is Processa Pharmaceuticals Inc a good long term investmentMomentum Stock Picks & Budget Friendly Trading Ideas - earlytimes.in
Relative strength of Processa Pharmaceuticals Inc. in sector analysisWeekly Trade Review & Step-by-Step Trade Execution Guides - newser.com
Order flow analysis tools used on Processa Pharmaceuticals Inc.July 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
Is Information Services Group Inc ZZG a good long term investmentMACD Histogram Signals & Discover High-Return Stocks Before They Boom - earlytimes.in
How to read the order book for Processa Pharmaceuticals Inc.Weekly Trading Summary & Verified Momentum Watchlists - newser.com
What data driven models say about Processa Pharmaceuticals Inc.’s futureBreakout Watch & Real-Time Buy Signal Alerts - newser.com
Using data filters to optimize entry into Processa Pharmaceuticals Inc.Quarterly Performance Summary & Weekly High Return Stock Opportunities - newser.com
Published on: 2025-10-30 23:43:44 - newser.com
Processa Pharmaceuticals Advances Breast Cancer Treatment with Phase 2 Study - TipRanks
Applying Wyckoff theory to Processa Pharmaceuticals Inc. stock2025 Market WrapUp & Safe Entry Zone Tips - newser.com
Can Processa Pharmaceuticals Inc. stock outperform in 2025 bull marketQuarterly Trade Summary & Step-by-Step Trade Execution Guides - newser.com
Is MillerKnoll Inc a good long term investmentRisk Mitigation Techniques & Superior Growth Trading - earlytimes.in
Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Processa Pharmaceuticals Inc-Aktie (PCSA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Ng George K | Chief Executive Officer |
Jan 27 '25 |
Buy |
0.80 |
87,200 |
69,542 |
87,200 |
| Young David | Pres. Research & Development |
Jan 27 '25 |
Buy |
0.80 |
124,500 |
99,289 |
205,405 |
| Lin Patrick | Chief Business - Strategy Off |
Jan 27 '25 |
Buy |
0.80 |
43,500 |
34,691 |
43,500 |
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):